S. Mizobata et al., Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen, CANCER IMMU, 49(6), 2000, pp. 285-295
In order to develop immunotherapy strategies that are based on eliciting im
mune responsiveness to the self-antigen, human carcinoembryonic antigen (CE
A), we examined whether cytotoxic T lymphocyte (CTL) activity against CEA c
ould be elicited in CEA-transgenic and nontransgenic mice. CEA-transgenic [
C57BL/6-TGN(CEAGe)18FJP] and nontransgenic mice were primed with CEA-transf
ected syngeneic fibroblasts in combination with Corynebacterium parvum. Spl
een cells from immunized mice were cultured with irradiated syngeneic MC-38
colon,carcinoma cells transfected with CEA (MC-38.CEA) as stimulators prio
r to the measurement of CTL activity. Primed nontransgenic spleen cells sho
wed augmented CTL activity against MC38.CEA cells as compared with control
parental MC-38 cells, nontransfected or transfected with vector only. Moreo
ver, primed CEA transgenic spleen cells showed augmented CTL activity again
st MC-38.CEA cells that was similar to that observed in nontransgenic mice.
All CTL clones derived from either transgenic or non-transgenic mice showe
d cross-reactivity with MC-38 cells expressing the CEA-related antigen, non
specific cross-reacting antigen, but not biliary glycoprotein. CEA-specific
CTL clones were not identified. Adoptive transfer of cloned CTL resulted i
n inhibition of MC38.CEA but not MC-38.BGP tumor growth. Tumor cures were e
licited in mice treated with a combination of cloned CTL and cyclophosphami
de. Histopathological examination of CEA-expressing colons from either immu
nized mice or recipients of cloned CTL did not reveal any autoimmune reacti
ons. These studies demonstrate that CTL recognizing cross-reactive class I
epitopes on the CEA molecule can be induced in transgenic mice. The express
ion of these epitopes on tumor cells creates effective targets for CTL in v
ivo without inducing adverse reactions in CEA-expressing normal tissues. Si
nce anti-CEA CTL have been generated in humans, CEA-transgenic mice may be
a useful model to study vaccines that are based on CTL effector mechanisms.